The first United Kingdom cases of a previously rare disease have been reported in gay men, reveals an editorial in the journal Sexually Transmitted Infections. Lymphograunuloma venereum (LGV) is a genital/anogenital bacterial infection caused by a particularly invasive strain of Chlamydia trachomatis. It was considered relatively rare until 2003, when around 100 cases were reported in gay men in Rotterdam in the Netherlands, most of whom were also HIV positive or had other sexually transmitted infections, including hepatitis C.
Since then outbreaks have been reported in Antwerp, Belgium, Hamburg, Germany, and Paris, France. Cases have also been reported in Sweden, and most recently in several U.S. cities, including New York, San Francisco, and Atlanta.
Last year, one of the UK's leading HIV charities, The Terrence Higgins Trust, and the Health Protection Agency, which monitors cases of the disease, took steps to alert clinicians and those most at risk to the spread of the infection.
In January 2005, the first 24 cases were reported in the UK, mostly from sexual health clinics in London. All were in gay men, 17 of whom were HIV positive. Four also had hepatitis C infection.
Five thought they had caught the infection in mainland Europe, while the others said they had become infected in the UK. By mid February, a total of 34 cases had been reported.
The infection usually manifests as an ulcer or papule, and symptoms usually include rectal inflammation (proctitis), rectal pain and bleeding, straining, constipation and abdominal pain. The infection may also be accompanied by fever and malaise. These can be treated with a three-week course of antibiotics; however, sometimes the primary ulcer goes unnoticed, and if left untreated, this can progress to chronic infection with the formation of skin pouches, abscesses, and narrowing of the anus as well as problems with the lymphatic system. In these cases, surgery is often necessary.
The authors suspect that the problem has been present for some time in the UK, with many cases going undiagnosed.
Source: Health Protection Agency
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.